Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
about
Identification of a lysosomal peptide transport system induced during dendritic cell developmentOptimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccinesHAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptidesAutophagy and intracellular surveillance: Modulating MHC class II antigen presentation with stressAlternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.Autophagy: A protective mechanism in response to stress and inflammation.Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigensIdentification of T-cell epitopes for cancer immunotherapy.Cytosol to lysosome transport of intracellular antigens during immune surveillance.Autophagy and its role in MHC-mediated antigen presentation.Autophagy and adaptive immunity.Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia.Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation.Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses.
P2860
Q24299256-BC2EFBC1-9FE8-423E-BEEF-A9ABA4BA06C7Q27030560-2D2532C7-5A91-4231-A25B-2B8636ACB5B1Q28301267-9BFC8440-5EE2-4BC7-97B2-D6BD2C855AB2Q33841283-BA575419-7CC0-4C91-9192-BF452783C9D4Q34155000-CA732B4A-6FB8-4E6E-B5AF-84693C4AA941Q36266489-576EF90F-3EA8-48FF-803B-CA6EFE2732F9Q36386903-EB817869-C565-4BC9-A07B-338D962A380BQ36490402-E1FA8704-AE90-4FF0-B42B-EB514DFC00EDQ36509997-68B3673A-D096-4A3F-84ED-E2F04C244CB0Q36870592-3876F760-ECE2-4425-B317-DE863FEDB024Q36960654-02A00B57-B5B2-41D8-A64A-45A594B672F3Q37315630-A2546142-AAD0-4C9C-89DE-ACF6DB46B142Q37768484-B82657B5-E8E8-451B-8354-B6F412034410Q37773237-E64C1ADA-65DC-4445-9F05-32B008F58AA9Q40244274-B600820F-0FD8-49B3-BE60-242C0440625CQ41966343-62B534A4-FC73-46D5-984A-737B5E035A8B
P2860
Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Presentation of endogenously s ...... processing and the proteasome.
@en
type
label
Presentation of endogenously s ...... processing and the proteasome.
@en
prefLabel
Presentation of endogenously s ...... processing and the proteasome.
@en
P2093
P1476
Presentation of endogenously s ...... processing and the proteasome.
@en
P2093
Natalia Tuera
Samudra K Dissanayake
Suzanne Ostrand-Rosenberg
P304
P356
10.4049/JIMMUNOL.174.4.1811
P407
P577
2005-02-01T00:00:00Z